Compare HSBC & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSBC | VEEV |
|---|---|---|
| Founded | 1865 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.5B | 39.5B |
| IPO Year | N/A | 2013 |
| Metric | HSBC | VEEV |
|---|---|---|
| Price | $74.87 | $222.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 27 |
| Target Price | N/A | ★ $299.92 |
| AVG Volume (30 Days) | 1.7M | ★ 1.9M |
| Earning Date | 10-28-2025 | 11-20-2025 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | ★ 26.69 |
| EPS | 0.93 | ★ 5.13 |
| Revenue | ★ $57,976,000,000.00 | $3,080,246,000.00 |
| Revenue This Year | $12.50 | $17.74 |
| Revenue Next Year | $2.06 | $12.24 |
| P/E Ratio | $80.68 | ★ $43.52 |
| Revenue Growth | 0.01 | ★ 15.96 |
| 52 Week Low | $45.66 | $201.54 |
| 52 Week High | $75.44 | $310.50 |
| Indicator | HSBC | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 67.11 | 18.87 |
| Support Level | $70.77 | $236.95 |
| Resistance Level | $72.24 | $246.57 |
| Average True Range (ATR) | 0.67 | 6.67 |
| MACD | 0.39 | -1.06 |
| Stochastic Oscillator | 91.48 | 22.23 |
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in more than 50 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.